| Bioactivity | Cyclosomatostatin TFA is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin TFA can inhibit somatostatin receptor type 1 (SSTR1) signaling and decreases cell proliferation, ALDH+ cell population size and sphere-formation in colorectal cancer (CRC) cells[1]. |
| Name | Cyclosomatostatin TFA |
| Shortening | Cyclo(KT-{Oaa}-FW) |
| Formula | C46H58F3N7O8 |
| Molar Mass | 893.99 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Cyclosomatostatin TFA
CAS: F: C46H58F3N7O8 W: 893.99
Cyclosomatostatin TFA is a potent somatostatin (SST) receptor antagonist. Cyclosomatostatin TFA can inhibit somatostatin
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.